TOP TIERMARKET NEWSWIRE
Movers explained · 2026-07-31

Archived explainer. For the current picture see today's GH page.

Why Is GUARDANT HEALTH INC (GH) Stock Up Today?

By the Top Tier Newswire AI Desk · July 31, 2026 at 9:44 AM ET · reviewed against 10 wire stories

GUARDANT HEALTH INC (GH) is up +9.61% in the latest session. Our newswire has captured 10 stories on GH across 7 sources in the last 36 hours, with AI sentiment reading bullish (avg 58/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Guardant Health Inc stock surged 9.61% to $166.99 in a sharp intraday rally driven by strong second-quarter 2026 results and raised full-year revenue guidance. The company reported 44% year-over-year revenue growth to $335 million and announced a new revenue target range of $1.34 billion to $1.36 billion for the year. The stock opened with a 6.1% gap up and reached an intraday high of $176.58 before settling near $166.99.

What Happened

Guardant Health posted a second-quarter revenue beat of $20.57 million and raised its full-year forecast, citing strong performance across oncology and screening, as well as recent FDA approvals. The company also announced a non-GAAP EPS of -$0.42, which missed estimates by $0.03. Despite the earnings miss, the revenue beat and guidance raise were enough to drive investor optimism. Mizuho and BTIG both raised their price targets for the stock, with Mizuho setting a new target of $200. The stock’s sharp move came after the SEC 8-K filing disclosed the preliminary results and financial statements.

What The Data Shows

The stock opened at $161.68 and traded as high as $176.58 within minutes of the market open. Volume in the session reached 0.6 million shares, which is 0.2 times the 3-month average. Over the past 8 sessions, the stock had moved down 0.2% from $152.63 to $152.35. Insider transactions over the last 90 days show 21 sales totaling $91.8 million, with the most recent sale reported on July 16. The stock currently trades at a market cap of $19.0 billion, with a trailing 12-month revenue growth of 39.6% and a net margin of -40.1%.

What To Watch

The stock’s next catalyst will be the full transcript and investor reactions to the July 30 earnings call. Analyst coverage and price target adjustments will be key to monitor in the coming days.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

GH by the numbers

Last: $166.99Session: +9.61%7 sessions: +8.70%Coverage: 10 stories / 7 sourcesAI sentiment: 58/100 (bullish)Mkt cap: $19.0B52w: $40.35 to $174.08
GH · Jul 31 session (5-min) · +6.33% vs prior close · updated 8:56 PM ET
$151$162$172prev close $152.35$162.007:00 AM9:55 AM12:50 PM3:45 PM6:40 PM7:00 AM · $161.687:05 AM · $161.007:40 AM · $163.707:45 AM · $164.708:25 AM · $162.318:30 AM · $162.018:50 AM · $161.008:55 AM · $161.539:00 AM · $161.509:10 AM · $162.009:15 AM · $163.009:20 AM · $162.109:25 AM · $161.029:30 AM · $168.319:35 AM · $164.659:40 AM · $165.689:45 AM · $167.499:50 AM · $170.719:55 AM · $168.7610:00 AM · $166.0910:05 AM · $165.1110:10 AM · $163.8410:15 AM · $163.0010:20 AM · $161.5810:25 AM · $162.8710:30 AM · $162.5310:35 AM · $162.1310:40 AM · $162.9110:45 AM · $163.1910:50 AM · $162.9610:55 AM · $164.1311:00 AM · $162.2111:05 AM · $162.7111:10 AM · $162.3711:15 AM · $161.6211:20 AM · $161.4711:25 AM · $161.4311:30 AM · $161.3111:35 AM · $161.6511:40 AM · $160.5111:45 AM · $160.4911:50 AM · $162.2511:55 AM · $161.7012:00 PM · $162.0912:05 PM · $161.3912:10 PM · $161.1912:15 PM · $161.8712:20 PM · $161.8712:25 PM · $161.8112:30 PM · $162.9612:35 PM · $162.8512:40 PM · $162.1912:45 PM · $162.5412:50 PM · $162.2612:55 PM · $161.141:00 PM · $161.461:05 PM · $161.411:10 PM · $161.511:15 PM · $161.331:20 PM · $161.981:25 PM · $162.631:30 PM · $161.221:35 PM · $161.731:40 PM · $161.311:45 PM · $160.631:50 PM · $160.581:55 PM · $161.042:00 PM · $161.492:05 PM · $161.782:10 PM · $161.532:15 PM · $161.632:20 PM · $161.952:25 PM · $162.122:30 PM · $161.672:35 PM · $161.842:40 PM · $162.082:45 PM · $161.892:50 PM · $161.872:55 PM · $161.463:00 PM · $162.223:05 PM · $162.093:10 PM · $161.243:15 PM · $161.583:20 PM · $161.413:25 PM · $161.243:30 PM · $161.393:35 PM · $160.353:40 PM · $161.723:45 PM · $161.363:50 PM · $161.943:55 PM · $162.024:00 PM · $161.994:15 PM · $162.506:25 PM · $161.506:40 PM · $162.00
AI sentiment, last 36h · averaged over 10 stories · 58/100 bullish
AI sentiment 58/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishSEC 8-K · sentiment 50 · Guardant Health, Inc. (GH) files 8-KSEC 8-K · 50Guardant Health, Inc. (GH) files 8-KSeeking Alpha · sentiment 56 · Guardant Health Non-GAAP EPS of -$0.42 misses by $0.03, revenue of $335M beats by $20.57MSeeking Alpha · 56Guardant Health Non-GAAP EPS of -$0.42 misses by $0.03, revenue of $335M beats by $20.57MInvesting.com Markets · sentiment 50 · Why is Guardant Health stock surging today?Investing.com Markets · 50Why is Guardant Health stock surging today?Seeking Alpha · sentiment 50 · Guardant Health, Inc. (GH) Q2 2026 Earnings Call TranscriptSeeking Alpha · 50Guardant Health, Inc. (GH) Q2 2026 Earnings Call TranscriptSeeking Alpha · sentiment 50 · Guardant Health, Inc. 2026 Q2 - Results - Earnings Call PresentationSeeking Alpha · 50Guardant Health, Inc. 2026 Q2 - Results - Earnings Call PresentationInvesting.com Analyst Ratings · sentiment 63 · BTIG raises Guardant Health stock price target on strong Q2 resultsInvesting.com Analyst Ratings · 63BTIG raises Guardant Health stock price target on strong Q2 resultsInvesting.com Analyst Ratings · sentiment 61 · Mizuho raises Guardant Health stock price target to $200 on volume beatInvesting.com Analyst Ratings · 61Mizuho raises Guardant Health stock price target to $200 on volume beatMarketChameleon · sentiment 73 · Guardant Health Raises 2026 Revenue Guidance on 44% Q2 Growth and Major Clinical Milestones July 31, 2026MarketChameleon · 73Guardant Health Raises 2026 Revenue Guidance on 44% Q2 Growth and Major Clinical Mileston…
10d agoMarketChameleonBULLISH 73Earnings

Guardant Health Raises 2026 Revenue Guidance on 44% Q2 Growth and Major Clinical Milestones July 31, 2026

Guardant Health posted strong second-quarter 2026 revenue growth and increased its full-year outlook, supported by broad-based gains in oncology and screening, a wave of major FDA approvals, and rising insurance adoption for its Shield test. See at-a-glance financials and what the revised guidance could signal for the company's next phase.

10d agoInvesting.com Analyst RatingsBULLISH 61Analyst

Mizuho raises Guardant Health stock price target to $200 on volume beat

Mizuho raises Guardant Health stock price target to $200 on volume beat

10d agoInvesting.com Analyst RatingsBULLISH 63Analyst

BTIG raises Guardant Health stock price target on strong Q2 results

BTIG raises Guardant Health stock price target on strong Q2 results

10d agoSeeking AlphaNEUTRAL 50Earnings

Guardant Health, Inc. 2026 Q2 - Results - Earnings Call Presentation

2026-07-31. The following slide deck was published by Guardant Health, Inc.

10d agoSeeking AlphaNEUTRAL 50Earnings

Guardant Health, Inc. (GH) Q2 2026 Earnings Call Transcript

Guardant Health, Inc. (GH) Q2 2026 Earnings Call July 30, 2026 4:30 PM EDTCompany ParticipantsZarak Khurshid - Vice President of Investor RelationsHelmy...

10d agoInvesting.com MarketsNEUTRAL 50General

Why is Guardant Health stock surging today?

Why is Guardant Health stock surging today?

11d agoSeeking AlphaBULLISH 56Earnings

Guardant Health Non-GAAP EPS of -$0.42 misses by $0.03, revenue of $335M beats by $20.57M

Guardant Health press release (GH): Q2 Non-GAAP EPS of -$0.42 misses by $0.03. Revenue of $335M (+44.3% Y/Y) beats by $20.57M. 2026 Guidance Guardant Health now

11d agoSEC 8-KNEUTRAL 50General

Guardant Health, Inc. (GH) files 8-K

Filed: 2026-07-30 AccNo: 0001576280-26-000036 Size: 473 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on GH: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier GH move explainers: 2026-07-31